|
Research
Wait and watch
Though scientists and pharma companies are aware of the potential
that DNA vaccines hold, they have still not arrived at any conclusion. Sachin
Jagdale reviews the developments
Its
been more than two hundred years since the discovery of first vaccine by Edward
Jenner. Jenner's discovery of smallpox vaccine resulted in almost complete eradication
of smallpox. Last two centuries witnessed the evolution of vaccines in many
different ways. Initially, vaccines used to have live attenuated infectious
material that was supposed to generate immune response inside the host body;
even today this is an often employed concept. Now, vaccines have come of age.
Advances in bacteriology and virology have led to more advanced form of vaccines.
One such vaccine that has caught the eye of medical fraternity is the DNA vaccine.
The health conscious world that has survived for a long time on a traditional
form of vaccine is now giving serious thought to DNA vaccines.
What is DNA Vaccination?
DNA vaccination is a technique wherein an organism will be
protected by injecting it with genetically-engineered DNA to produce an immunological
response. DNA vaccines are also known as nucleic acid vaccines. However, these
vaccines are still experimental, and have been applied to a number of bacterial,
viral and parasitic models of disease, as well as to numerous tumour models.
Although DNA vaccine is a highly controversial issue, genetic
material has been used for therapeutic purpose since the last fifty years. Scientists
like Griffith had transferred DNA into cells of living animals in the early
1930. In 1943, Oswald Avery proved that DNA carries genetic information. Post
1950, experiments were conducted using purified genetic material. Such experiments
provided the solid evidence that direct injection of DNA gene results in the
expression of the inoculated gene in the host and this too in the absence of
vector. As far as DNA vaccine is concerned, it was accidently discovered by
scientists Tang and Johnson.
"The
'foreign' DNA from the DNA vaccines could become integrated into the chromosomes
of the host cells."
- Sanjeev Saxena
Chair man and CEO
Actis Biologics
|
"DNA
vaccines are non-infectious, economical to produce in large amounts and
easy to purify using simple and inexpensive procedures"
- P N Rangarajan
Associate Professor,
Department of Biochemistry
Indian Institute of Science
|
Construction of DNA Vaccine
DNA vaccine is made up of double stranded circular DNA called
plasmid. This plasmid is genetically engineered and is capable of producing
specific protein (antigens). Plasmids used in DNA based vaccines are usually
composed of an expression unit and a production unit. Expression unit has promoter
sequences that are followed by antigen encoding and polyadenylation sequences,
while production unit is composed of bacterial sequences, which would amplify
plasmid. Vaccine inserts are fitted into the bacterial plasmid by using recombinant
DNA technology. Once this unit is ready, vaccine plasmid is introduced into
bacteria where bacterial growth produces multiple plasmid copies. The purified
form of this plasmid DNA acts as a vaccine.
|
1796 Edward Jenner develops smallpox vaccine
1885 Pasteur develops rabies vaccine
1955 Injectable polio vaccine introduced
1962 Oral polio vaccine introduced
1967 Smallpox eradication program started
1979 Smallpox eradicated from the world
1986 First recombinant human vaccine
1994 Last case of polio in the Americas
1998 Infant immunisation rate ~80%
1999 Eradication of polio and measles in sight
Source-Co-operative Research Center For Vaccine Technology, Australia
|
Why DNA vaccine?
Genetic engineers do not make new genes, they rearrange existing ones. The
headway in genetics has proved critical in finding out remedies to many kinds
of diseases. DNA vaccine is one such weapon of genetic engineering. Renowned
American author George F Will has rightly said that a disquieting era of genetic
manipulation is in the offing, that may revolutionise human capacities, and
notions of health. When for more than 150 years, conventional vaccines are successfully
treating the masses, up to the level of satisfaction, why do we need DNA vaccine?
PN Rangarajan, Associate Professor, Department of Biochemistry, Indian Institute
of Science, Bangalore justifies the need by pointing out the advantages of this
vaccine. "In case of DNA vaccination, since the pathogenic protein is synthesised
in its native form inside the host cell, the chances of vaccine failure are
minimal. In addition, DNA vaccines are non-infectious, economical to produce
in large amounts and easy to purify using simple and inexpensive procedures.
Moreover, all DNA vaccines can be produced using similar fermentation, purification
and validation techniques, " he says.
Benefits of DNA vaccines are many and they are far from over.
Rangarajan briefs about the cost effectiveness of DNA vaccines. "DNA vaccines
do not require cold-chain and it can be stored either dry or in an aqueous solution
at room temperature. Cold-chain is the series of refrigerators required to maintain
the viability of a vaccine during distribution. Currently, maintaining the cold-chain
represents nearly 80 per cent of the cost of vaccinating individuals in developing
nations," informs Rangarajan.
|
Many vaccines began as serendipitous discoveries. Louis Pasteur discovered
attenuated vaccines when old cholera cultures lost their virulence. When
chickens were inoculated with aged cultures, they unexpectedly developed
immunity to cholera. Similarly, DNA vaccination was discovered by chance
when a group of researchers in the United States observed that mouse skeletal
muscle can take up naked DNA and express proteins encoded by the DNA.
Naked DNA was actually used as a control in their experiments whose objective
was to identify lipids that enhance DNA delivery in to skeletal muscle.
When DNA encoding an influenza virus protein was injected in to the skeletal
muscle of mice, synthesis of the virus protein in the mouse muscle triggered
an immune response resulting in protection of the mice from a subsequent
influenza infection. These results published in Science in the year 1993
marked the beginning of DNA vaccines also known as nucleic acid vaccines
or genetic vaccines.
Source- P N Rangarajan, Associate Professor, Department of Biochemistry,
Indian Institute of Science, Bangalore
|
|
In developing countries where the tropical and infectious diseases are
rampant, conventional vaccines have been key in preventing millions of
cases of killer diseases such as small-pox and polio but some pathogens,
such as malaria, have proven to be a considerable challenge to vaccine
developers. It is in such cases that DNA vaccines may prove useful. Already,
a promising DNA vaccine candidate has been developed for malaria. DNA
vaccines are also currently being developed for over 15 other human illnesses
including AIDS, herpes, tuberculosis and rotavirus, a common cause of
childhood diarrhoea. Some of the companies working in this area are Inovio,
Vical, VGX Pharma, Ichor, DNAX.
Source-Sanjeev Saxena, Chairman and CEO, Actis Biologics
|
Better but not Best
DNA vaccines are undoubtedly more effective and economical than conventional
vaccines but they are not devoid of side effects. Sanjeev Saxena, Chairman and
CEO, Actis Biologics says, "The 'foreign' DNA from the DNA vaccines could
become integrated into the chromosomes of the host cells. The effect of such
integration of DNA into a chromosome could range from no effect whatsoever to
potentially catastrophic results such as inducing cancer through alteration
of normal DNA. The effect of continuous antigen production in situ may also
cause a hyperactive immune response leading to anaphylactic shock, systemic
organ failure and death."
The list of worries does not end here. The mechanism of DNA vaccine action is
still not well understood. There are still many questions on the use of DNA
vaccines. Rangarajan raises some key queries. He asks, "Does DNA vaccination
obey classical rules of inducing immune responses or are DNA-transfected muscle
cells or skin cells, and not lymphoid cells, presenting the antigen? If lymphoid
cells present the antigen, how do they obtain the antigen? Does DNA directly
transfect these cells, or do they acquire protein from transfected skin or muscle
cells?" Rangarajan adds, "Since expression of the plasmid encoded
antigen appears to persist for a long time, there is a concern that unresponsiveness
might result, rather than protective immunity. Another major concern is the
induction of anti-DNA antibodies by plasmid DNA. Antibodies to DNA can cause
disease."
What is Next?
Amidst enormous hope and suspicion, it will be interesting to see how long it
takes to use DNA vaccines for human purpose. Scientists are keen on reducing
the drawbacks of DNA vaccines but it continues to remain a 'do-not-access' vaccine.
Saxena opines, "While DNA vaccines will be yet another weapon in the armamentarium
of vaccines to prevent and treat disease in addition to the so-called conventional
or traditional vaccines, it cannot be replaced entirely."
If Rangarajan is to be believed, unrealistic expectations and hype could lead
to backlash, if hope fails to become reality in a timely fashion. Thus, we have
no choice but to wait and watch until the results are more reliable.
Glossary of terms
Plasmid: A plasmid is an extrachromosomal DNA molecule,
separate from the chromosomal DNA and capable of autonomous replication.
Vector: In molecular biology and genetic engineering
a vector is a vehicle for transferring genetic material into a cell.
Recombinant DNA: It is a form of artificial DNA that
is engineered through the combination or insertion of one or more DNA strands,
thereby combining DNA sequences that would not normally occur together.
Antigen: An antigen (from antibody generating) or
immunogen is a molecule that sometimes stimulates an immune response.
Antibodies: Antibodies or immunoglobulin are proteins
that are found in blood or other bodily fluids of vertebrates, and are used
by the immune system to identify and neutralise foreign objects, such as bacteria
and viruses.
sachin.jagdale@expressindia.com
|